G J Locker - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

G J Locker

Showing results (51-60 of 55) with videos related to

Pageof 6

Sort By:

You have reached the last page of results.This site can display upto 55 results.

Journal of Immunotherapy (Hagerstown, Md. : 1997)|January 30, 1999

Induction of immunomediated diseases by recombinant human granulocyte-macrophage colony-stimulating factor during cancer treatment?G J Locker, G G Steger, M F Gnant, et al.

Journal of Clinical Anesthesia|October 12, 2000

Prostaglandin E(1) does not influence plasmatic coagulation, hepatic synthesis, or postoperative blood loss in patients after coronary-artery bypass graftingG J Locker, M Grimm, H Losert, et al.

British Journal of Haematology|November 11, 1999

Activation of endothelium by immunotherapy with interleukin-2 in patients with malignant disordersG J Locker, S Kapiotis, M Veitl, et al.

The Journal of Pharmacology and Experimental Therapeutics|June 25, 1999

Negative chronotropic effects of fentanyl attenuate beneficial effects of dobutamine on oxygen metabolism: hemodynamic and pharmacokinetic interactionsG J Locker, R M Mader, B Rizovski, et al.

Cancer Chemotherapy and Pharmacology|February 28, 2001

Docetaxel monotherapy in heavily pretreated metastatic breast cancer: a multicenter, community-based feasibility trialM Schmidinger, A C Budinsky, C Wenzel, et al.

Pageof 6

Search research articles

Showing results (51-60 of 55) with videos related to

Sort By:

Pageof 6

You have reached the last page of results.This site can display upto 55 results.

Journal of Immunotherapy (Hagerstown, Md. : 1997)|January 30, 1999

Induction of immunomediated diseases by recombinant human granulocyte-macrophage colony-stimulating factor during cancer treatment?G J Locker, G G Steger, M F Gnant, et al.

Journal of Clinical Anesthesia|October 12, 2000

Prostaglandin E(1) does not influence plasmatic coagulation, hepatic synthesis, or postoperative blood loss in patients after coronary-artery bypass graftingG J Locker, M Grimm, H Losert, et al.

British Journal of Haematology|November 11, 1999

Activation of endothelium by immunotherapy with interleukin-2 in patients with malignant disordersG J Locker, S Kapiotis, M Veitl, et al.

The Journal of Pharmacology and Experimental Therapeutics|June 25, 1999

Negative chronotropic effects of fentanyl attenuate beneficial effects of dobutamine on oxygen metabolism: hemodynamic and pharmacokinetic interactionsG J Locker, R M Mader, B Rizovski, et al.

Cancer Chemotherapy and Pharmacology|February 28, 2001

Docetaxel monotherapy in heavily pretreated metastatic breast cancer: a multicenter, community-based feasibility trialM Schmidinger, A C Budinsky, C Wenzel, et al.

Pageof 6